- Home
- OGEN vs FOXO Comparison
OGEN vs FOXO Comparison
Compare OGEN & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGEN
- FOXO
- Stock Information
- Founded
- OGEN 1996
- FOXO 2019
- Country
- OGEN United States
- FOXO United States
- Employees
- OGEN N/A
- FOXO N/A
- Industry
- OGEN Biotechnology: Pharmaceutical Preparations
- FOXO Retail: Computer Software & Peripheral Equipment
- Sector
- OGEN Health Care
- FOXO Technology
- Exchange
- OGEN Nasdaq
- FOXO Nasdaq
- Market Cap
- OGEN 4.6M
- FOXO 3.9M
- IPO Year
- OGEN N/A
- FOXO N/A
- Fundamental
- Price
- OGEN $0.20
- FOXO $0.08
- Analyst Decision
- OGEN
- FOXO
- Analyst Count
- OGEN 0
- FOXO 0
- Target Price
- OGEN N/A
- FOXO N/A
- AVG Volume (30 Days)
- OGEN 376.3K
- FOXO 7.4M
- Earning Date
- OGEN 05-14-2025
- FOXO 04-15-2025
- Dividend Yield
- OGEN N/A
- FOXO N/A
- EPS Growth
- OGEN N/A
- FOXO N/A
- EPS
- OGEN N/A
- FOXO N/A
- Revenue
- OGEN N/A
- FOXO $4,051,601.00
- Revenue This Year
- OGEN N/A
- FOXO N/A
- Revenue Next Year
- OGEN N/A
- FOXO N/A
- P/E Ratio
- OGEN N/A
- FOXO N/A
- Revenue Growth
- OGEN N/A
- FOXO 2688.61
- 52 Week Low
- OGEN $0.16
- FOXO $0.07
- 52 Week High
- OGEN $3.43
- FOXO $1.30
- Technical
- Relative Strength Index (RSI)
- OGEN 43.74
- FOXO 27.56
- Support Level
- OGEN $0.16
- FOXO $0.07
- Resistance Level
- OGEN $0.21
- FOXO $0.12
- Average True Range (ATR)
- OGEN 0.01
- FOXO 0.01
- MACD
- OGEN 0.00
- FOXO -0.00
- Stochastic Oscillator
- OGEN 74.00
- FOXO 17.72
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.
About FOXO FOXO Technologies Inc.
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.